Mindfulness and Lifestyle Interventions for Depression and Anxiety: A Pilot Study

Sponsor
Arizona State University (Other)
Overall Status
Unknown status
CT.gov ID
NCT01230047
Collaborator
(none)
30
1
2
12
2.5

Study Details

Study Description

Brief Summary

This is a quasi-experimental evaluation of psychoeducational course focusing on mindfulness and lifestyle changes for depression and anxiety; clients in active treatment group are compared to those in a treatment-as-usual wait-list control group. The primary hypothesis is that the psychoeducational course will result in lower levels of depression and anxiety as compared to the wait-listed treatment-as-usual comparison group.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Psychoeducational course
N/A

Detailed Description

This study evaluates a psychoeducational intervention: Teaching mindfulness and lifestyle interventions to adult clients who self-report problems with depression and/or anxiety. The course is eight weeks long. Clients are assigned to either (1) receive the course (COU condition) from October- December 2010 or (2) placed on a waiting list and receive treatment-as-usual (TAU condition). Those in the TAU group will be offered the course in January 2011.

Random assignment to COU or TAU conditions will be attempted although this may be relaxed due to institutional constraints.

Participants are assessed on the Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI) at the beginning of the course, on the last day of the course, at 1-month post-course, at 4-months post-course, and at 12-months post-course.

Participants in the COU condition will be compared to those in TAU condition at the beginning of the course, on the last day of the course, and at 1-month post-course. Further evaluations (4 and 12 months post-course) will be pre-post evaluations without a comparison group.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Evaluation of a Psychoeducational Intervention Teaching Mindfulness and Lifestyle Interventions for Clinical Depression and Anxiety (A Pilot Study)
Study Start Date :
Oct 1, 2010
Anticipated Primary Completion Date :
Jan 1, 2011
Anticipated Study Completion Date :
Oct 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: Psychoeducational Course

In this arm, clients receive the psychoeducational course.

Behavioral: Psychoeducational course
Psychoeducational course on mindfulness and lifestyle interventions for depression and anxiety
Other Names:
  • Psychoeducational, therapeutic, psychosocial, self-help
  • No Intervention: Treatment-as-usual/Waiting list

    Clients assigned to this condition will receive treatment-as-usual (TAU) and be placed on a waiting list.

    Outcome Measures

    Primary Outcome Measures

    1. Beck Depression Inventory (BDI) [BDI administered at 12 weeks]

      Depression will be assessed by comparing BDI scores on day one with BDI scores at twelve weeks (four weeks after conclusion of the psychoeducational course). The primary study hypothesis is that the psychoeducational course group will have a greater reduction in BDI scores when compared to the treatment-as-usual wait-listed comparison group.

    Secondary Outcome Measures

    1. Beck Anxiety Inventory (BAI) [BAI administered at 8 weeks]

    2. Beck Anxiety Inventory (BAI) [BAI administered at 12 weeks]

    3. Beck Anxiety Inventory (BAI) [BAI administered at 24 weeks]

    4. Beck Anxiety Inventory (BAI) [BAI administered at 60 weeks]

    5. Beck Depression Inventory (BDI) [BDI administered at 8 weeks]

    6. Beck Depression Inventory (BDI) [BDI administered at 24 weeks]

    7. Beck Depression Inventory (BDI) [BDI administered at 60 weeks]

    8. Beck Anxiety Inventory (BAI) [BAI administered at Day 1 of Study]

    9. Beck Depression Inventory (BDI) [BDI administered at Day 1 of Study]

    10. Client Medication Use [Measured on Day 1 of Study]

      Clients fill out a survey which includes a question asking if they are currently taking psychiatric medication.

    11. Client Medication Use [Measured at 8 weeks]

      Clients fill out a survey which includes a question asking if they are currently taking psychiatric medication.

    12. Client Medication Use [Measured at 12 weeks]

      Clients fill out a survey which includes a question asking if they are currently taking psychiatric medication.

    13. Client Medication Use [Measured at 24 weeks]

      Clients fill out a survey which includes a question asking if they are currently taking psychiatric medication.

    14. Client Medication Use [Measured at 60 weeks]

      Clients fill out a survey which includes a question asking if they are currently taking psychiatric medication.

    15. Client Currently Seeing Therapist [Measured on Day 1 of study]

      Clients are given a survey which includes a question asking if they are currently seeing a clinician for psychotherapy.

    16. Client Currently Seeing Therapist [Measured at week 8]

      Clients are given a survey which includes a question asking if they are currently seeing a clinician for psychotherapy.

    17. Client Currently Seeing Therapist [Measured at week 12]

      Clients are given a survey which includes a question asking if they are currently seeing a clinician for psychotherapy.

    18. Client Currently Seeing Therapist [Measured at week 24]

      Clients are given a survey which includes a question asking if they are currently seeing a clinician for psychotherapy.

    19. Client Currently Seeing Therapist [Measured at week 60]

      Clients are given a survey which includes a question asking if they are currently seeing a clinician for psychotherapy.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Participants self-report as having depression or anxiety

    • Adults (age 18 or above)

    • Clients willing to participate in an 8-week psychoeducational course

    Exclusion Criteria:
    • A diagnosis of a psychotic disorder

    • Unwilling to participate in 8-week psychoeducational course

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Utah Youth Village Salt Lake City Utah United States 84121

    Sponsors and Collaborators

    • Arizona State University

    Investigators

    • Principal Investigator: Jeffrey R Lacasse, PhD, Arizona State University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01230047
    Other Study ID Numbers:
    • 1018
    First Posted:
    Oct 28, 2010
    Last Update Posted:
    Oct 28, 2010
    Last Verified:
    Oct 1, 2010
    Keywords provided by , ,
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 28, 2010